Search Results

There are 32850 results for: content related to: Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HB sAg seroclearance

  1. You have free access to this content
    New therapeutic perspectives in HBV: when to stop NAs

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 146–153, Cristina Pérez-Cameo, Mònica Pons and Rafael Esteban

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12398

  2. Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 130–139, François Habersetzer, Rémy Moenne-Loccoz, Nicolas Meyer, Evelyne Schvoerer, Pauline Simo-Noumbissie, Stavros Dritsas, Thomas F. Baumert and Michel Doffoël

    Version of Record online : 15 SEP 2014, DOI: 10.1111/liv.12661

  3. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk

    Liver International

    Volume 34, Issue 5, May 2014, Pages: 728–736, Yifang Han, Rui Pu, Xue Han, Jun Zhao, Weiping Li, Jianhua Yin, Yuwei Zhang, Qiuxia Shen, Jiaxin Xie, Qi Zhang, Shuang Jiang, Juhong Li, Hongwei Zhang, Hongyang Wang and Guangwen Cao

    Version of Record online : 1 OCT 2013, DOI: 10.1111/liv.12313

  4. HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy

    Liver International

    Volume 35, Issue 4, April 2015, Pages: 1290–1302, Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, Taito Fukushima, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi and Hiromitsu Kumada

    Version of Record online : 28 AUG 2014, DOI: 10.1111/liv.12652

  5. You have free access to this content
    HBsAg quantification: useful for monitoring natural history and treatment outcome

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 97–107, Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12403

  6. Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearance

    Liver International

    Volume 36, Issue 5, May 2016, Pages: 642–650, Wai-Kay Seto, Yasuhito Tanaka, Danny K.-H. Wong, Noboru Shinkai, Ka-Shing Cheung, Kevin S.-H. Liu, James Fung, Ching-Lung Lai and Man-Fung Yuen

    Version of Record online : 5 NOV 2015, DOI: 10.1111/liv.12980

  7. You have free access to this content
    The role of HBsAg quantification for monitoring natural history and treatment outcome

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 125–132, Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12075

  8. Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA

    Liver International

    Volume 35, Issue 6, June 2015, Pages: 1692–1699, Junfeng Lu, Shibin Zhang, Yali Liu, Xiaofei Du, Shan Ren, Hua Zhang, Lina Ma, Yue Chen, Xinyue Chen and Chengli Shen

    Version of Record online : 21 JAN 2015, DOI: 10.1111/liv.12753

  9. You have free access to this content
    HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 82–90, Michelle Martinot-Peignoux, Tarik Asselah and Patrick Marcellin

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12735

  10. You have free access to this content
    What can we learn from hepatitis B virus clinical cohorts?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 91–99, Chih-Lin Lin, Tai-Chung Tseng and Jia-Horng Kao

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12716

  11. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously

    Liver International

    Volume 34, Issue 6, July 2014, Pages: e71–e79, Huei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, Ting-Chih Chen, Tai-Chung Tseng, Chen-Hua Liu, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen and Chun-Jen Liu

    Version of Record online : 2 OCT 2013, DOI: 10.1111/liv.12324

  12. You have free access to this content
    Virological and serological tools to optimize the management of patients with chronic hepatitis B

    Liver International

    Volume 36, Issue S1, January 2016, Pages: 78–84, Michelle Martinot-Peignoux and Patrick Marcellin

    Version of Record online : 4 JAN 2016, DOI: 10.1111/liv.12998

  13. Use of hepatitis B surface and “e” antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 795–804, Anders Boyd, Sarah Maylin, Joël Gozlan, Constance Delaugerre, François Simon, Pierre-Marie Girard and Karine Lacombe

    Version of Record online : 30 MAR 2014, DOI: 10.1111/liv.12521

  14. You have free access to this content
    HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 112–119, Jia-Horng Kao

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12400

  15. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 127–132, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12404

  16. HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers

    Liver International

    Volume 34, Issue 7, August 2014, Pages: e238–e245, Simon B. Larsson, Anders Eilard, Sebastian Malmström, Charles Hannoun, Amar P. Dhillon, Gunnar Norkrans and Magnus Lindh

    Version of Record online : 25 OCT 2013, DOI: 10.1111/liv.12345

  17. You have free access to this content
    Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 100–106, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12719

  18. On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1540–1548, Ioannis Goulis, Stylianos Karatapanis, Evangelos Akriviadis, Melanie Deutsch, George N. Dalekos, Maria Raptopoulou-Gigi, Konstantinos Mimidis, George Germanidis, Christos Drakoulis, Christos Triantos, Elias Zintzaras, Georgios Bakalos and George Papatheodoridis

    Version of Record online : 20 NOV 2014, DOI: 10.1111/liv.12725

  19. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 854–859, James Fung, Wai-kay Seto, Danny Ka-ho Wong, Ching-lung Lai and Man-fung Yuen

    Version of Record online : 4 JUN 2014, DOI: 10.1111/liv.12596

  20. You have free access to this content
    Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 157–163, Pietro Lampertico, Mauro Viganò and Massimo Colombo

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12064